Australia’s housing finance continued to fall in December, with the largest falls seen for owner-occupiers. Finance for first home buyers, which had previously outperformed other segments, fell sharply in December.
Total financing is down 20 percent over the last year, and further falls are likely in the near term. A sustained improvement in housing finance would be an early indicator of a stabilisation in the housing market.
The value of housing finance commitments fell at a faster rate in December. Finance approvals are now 20 percent lower over the year. Further declines are likely as tighter lending standards continue to filter through, ANZ Research reported.
The value of finance for owner-occupiers fell 6.4 percent m/m, leaving it 16.2 percent lower for the year. Investor finance fell 4.6 percent in the month and is 27.8 percent lower year on year.
Within the owner-occupier category, the trend of first home buyer outperformance has ended, as it declined 8 percent m/m. As a share of the value of total housing finance (excluding refinancing), first home buyers were 16 percent, down from 17 percent in November. It appears that tighter lending standards are now affecting this segment.


Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Gold and Silver Prices Climb in Asian Trade as Markets Eye Key U.S. Economic Data
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Lee Seung-heon Signals Caution on Rate Hikes, Supports Higher Property Taxes to Cool Korea’s Housing Market
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



